Akhilesh Yadav wins from Kannauj with margin of around 1.70 lakh

Akhilesh Yadav wins from Kannauj with margin of around 1.70 lakh

Samajwadi Party chief Akhilesh Yadav won the Kannauj Lok Sabha seat in Uttar Pradesh on Tuesday by a margin of 1,70,000 votes over his nearest rival and BJP MP Subrata Pathak. According to Election Commission data, Yadav got 6,42,292 votes while Pathak polled 4,71,370 votes. BSP’s Imran Bin Zafar got 81,639 votes. Under Yadav’s leadership, … Read more

Mphasis management on company performance, growth outlook and more

Mphasis management on company performance, growth outlook and more

“A lot of this is driven through everything we talked about in the last few quarters, the focus on in-account actions, extreme amount of focus on investing in relevant tech solutions, infusing a lot of tech and AI into these solutions to actually create a differentiation,” says Nitin Rakesh, CEO, Mphasis.Meanwhile, Manish Dugar, CFO, Mphasis … Read more

Equities beat others by a wide margin in alpha

Equities beat others by a wide margin in alpha

Equities have been the most consistent performer among asset classes across various periods in the past decade. The Nifty has returned 14% annualised returns in the previous 10 years, while gold has gained 7.3%. Gold has, however, caught up with the Nifty in both one-year and five-year periods. Although interest rates have spiked in the … Read more

For risk takers: 4 midcap stocks from different sectors with high ROE & ROCE

For risk takers: 4 midcap stocks from different sectors with high ROE & ROCE

In addition to these scores, the report also contains trend analysis, peer analysis and mean analysts’ recommendations to help an investor make better & informed investment decisions. Synopsis While nifty last week witnessed minor corrective movement, the overall trend is still bullish and so are the risk levels. In such times, it would be better … Read more

ETMarkets Smart Talk: Why are FMCG stocks trading at record highs? Kaizad Hozdar explains

ETMarkets Smart Talk: Why are FMCG stocks trading at record highs? Kaizad Hozdar explains

“The Nifty FMCG index is at its peak currently. Many stocks including ITC, Varun Beverages, Britannia, and Nestle are gliding higher especially given that they have delivered good numbers in the quarter gone by,” says Kaizad Hozdar – Investment Advisor, TrustPlutus Wealth. In an interview with ETMarkets, Hozdar said: “After a brutal 2022 when margins … Read more

Time to look at pharma and speciality chemicals sector: Anand Tandon

Time to look at pharma and speciality chemicals sector: Anand Tandon

” I think there is a longer-term challenge to the business. Near-term, of course, the deal gains have been fairly robust. So this year is going to be definitely a challenging year for the IT sector. I think the market has already realized that and has traded it down. What we are looking now is … Read more

ETMarkets Fund Manager Talk: For markets, sustenance of earnings growth crucial over next few years: Shibani Sircar, Kotak AMC

ETMarkets Fund Manager Talk: For markets, sustenance of earnings growth crucial over next few years: Shibani Sircar, Kotak AMC

The earnings trend will have to sustain not just in this quarter but over the next few years for the markets, says Shibani Sircar Kurian of Kotak Mahindra Asset Management Co. “Some of the key factors to watch out for include trends in discretionary consumption and demand, any improvement in rural demand trajectory and margin … Read more

UltraTech Cement Q3 Results: Profit drops 38% YoY to Rs 1,058 crore, revenue up 19.5%

UltraTech Cement Q3 Results: Profit drops 38% YoY to Rs 1,058 crore, revenue up 19.5%

Aditya Birla Group company UltraTech Cement today reported 38% on-year drop in its consolidated net profit at Rs 1,058.20 crore in the December quarter. Its revenue from operations, however, rose 19.5% YoY to Rs 15,520.93 crore. The company’s operating margin dropped to 15% in Q3 from 19% in the year-ago period but was up 100 … Read more

US speciality biz, India rebound help Sun Pharma shine in Q2

US speciality biz, India rebound help Sun Pharma shine in Q2

The management intends to ramp up the speciality business to a reasonable scale before allocating investments in new areas. Synopsis India business, contributing a third of the company’s consolidated revenues, grew on the back of a recovery in non-Covid drug therapies leading to gains for the industry leader. The market is gradually moving back to … Read more